IN2014DN10691A - - Google Patents
Info
- Publication number
- IN2014DN10691A IN2014DN10691A IN10691DEN2014A IN2014DN10691A IN 2014DN10691 A IN2014DN10691 A IN 2014DN10691A IN 10691DEN2014 A IN10691DEN2014 A IN 10691DEN2014A IN 2014DN10691 A IN2014DN10691 A IN 2014DN10691A
- Authority
- IN
- India
- Prior art keywords
- metabolites
- propanamide
- benzofuranyl
- cyclopropyl
- dihydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Abstract
Isolated metabolites of (1 R trans) N [[2 (2 3 dihydro 4 benzofuranyl)cyclopropyl] methyl]propanamide methods for their use and compositions containing the metabolites.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261649220P | 2012-05-18 | 2012-05-18 | |
PCT/US2013/041573 WO2013173707A1 (en) | 2012-05-18 | 2013-05-17 | Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN10691A true IN2014DN10691A (en) | 2015-08-28 |
Family
ID=48483244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN10691DEN2014 IN2014DN10691A (en) | 2012-05-18 | 2013-05-17 |
Country Status (18)
Country | Link |
---|---|
US (4) | US9212129B2 (en) |
EP (1) | EP2855424B1 (en) |
JP (1) | JP5959083B2 (en) |
KR (3) | KR20150005691A (en) |
CN (2) | CN104583178A (en) |
AU (1) | AU2013262631B2 (en) |
BR (1) | BR112014028446A2 (en) |
CA (1) | CA2872324C (en) |
CL (1) | CL2014003126A1 (en) |
CO (1) | CO7151504A2 (en) |
ES (1) | ES2648987T3 (en) |
IL (1) | IL235485A (en) |
IN (1) | IN2014DN10691A (en) |
MX (1) | MX2014014010A (en) |
NZ (1) | NZ701515A (en) |
RU (1) | RU2632889C2 (en) |
WO (1) | WO2013173707A1 (en) |
ZA (1) | ZA201408014B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2855424B1 (en) | 2012-05-18 | 2017-10-11 | Vanda Pharmaceuticals Inc. | Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide |
WO2015117048A1 (en) * | 2014-01-31 | 2015-08-06 | Vanda Pharmaceuticals Inc. | Treatment of circadian rhythm disorders |
BR112021004214A2 (en) * | 2018-09-12 | 2021-05-25 | Vanda Pharmaceuticals Inc. | method for improving sleep, post-sleep performance, or both, and improvement in a method |
AU2020221347B2 (en) * | 2019-02-13 | 2022-08-25 | Mihael Polymeropoulos | Method of improving sleep |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2176854A1 (en) | 1995-06-07 | 1996-12-08 | Daniel J. Keavy | N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
RU2190609C2 (en) * | 1996-12-10 | 2002-10-10 | Бристол-Маерс Сквибб Компани | Derivatives of benzodioxol, benzofuran, dihydrobenzofuran and benzodioxane and compositions comprising thereof |
WO2003037337A1 (en) | 2001-10-30 | 2003-05-08 | Novartis Ag | Depot formulations of iloperidone and a star polymer |
GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
MX2008014843A (en) | 2006-05-22 | 2008-12-05 | Vanda Pharmaceuticals Inc | Treatment for depressive disorders. |
DK2806863T3 (en) | 2012-01-26 | 2017-10-30 | Vanda Pharmaceuticals Inc | Treatment of circadian rhythm disorders |
EP2855424B1 (en) * | 2012-05-18 | 2017-10-11 | Vanda Pharmaceuticals Inc. | Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide |
-
2013
- 2013-05-17 EP EP13724708.6A patent/EP2855424B1/en active Active
- 2013-05-17 CN CN201380025225.6A patent/CN104583178A/en active Pending
- 2013-05-17 BR BR112014028446A patent/BR112014028446A2/en not_active Application Discontinuation
- 2013-05-17 NZ NZ701515A patent/NZ701515A/en unknown
- 2013-05-17 JP JP2015512886A patent/JP5959083B2/en active Active
- 2013-05-17 AU AU2013262631A patent/AU2013262631B2/en active Active
- 2013-05-17 ES ES13724708.6T patent/ES2648987T3/en active Active
- 2013-05-17 CA CA2872324A patent/CA2872324C/en active Active
- 2013-05-17 IN IN10691DEN2014 patent/IN2014DN10691A/en unknown
- 2013-05-17 MX MX2014014010A patent/MX2014014010A/en active IP Right Grant
- 2013-05-17 KR KR1020147033530A patent/KR20150005691A/en not_active Application Discontinuation
- 2013-05-17 CN CN201811055156.4A patent/CN108997160A/en active Pending
- 2013-05-17 RU RU2014151161A patent/RU2632889C2/en active
- 2013-05-17 KR KR1020177015054A patent/KR101891299B1/en active IP Right Grant
- 2013-05-17 KR KR1020187023795A patent/KR20180095737A/en active Search and Examination
- 2013-05-17 US US14/401,857 patent/US9212129B2/en active Active
- 2013-05-17 WO PCT/US2013/041573 patent/WO2013173707A1/en active Application Filing
-
2014
- 2014-11-03 ZA ZA2014/08014A patent/ZA201408014B/en unknown
- 2014-11-03 IL IL235485A patent/IL235485A/en active IP Right Grant
- 2014-11-18 CL CL2014003126A patent/CL2014003126A1/en unknown
- 2014-11-25 CO CO14259603A patent/CO7151504A2/en unknown
-
2015
- 2015-11-10 US US14/937,786 patent/US9617203B2/en active Active
-
2017
- 2017-03-02 US US15/447,946 patent/US9850199B2/en active Active
- 2017-12-08 US US15/836,099 patent/US10233142B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019500176A1 (en) | Heterocyclic compounds and ther uses | |
AU2016202480A1 (en) | Seed-origin endophyte populations, compositions, and methods of use | |
IN2015DN00127A (en) | ||
EP2885399A4 (en) | Bacillus megaterium bioactive compositions and metabolites | |
MX2013008390A (en) | Preparation of metal-triazolate frameworks. | |
MY179933A (en) | Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use thereof | |
GEP201706745B (en) | Forms of rifaximin and usage thereof | |
MY172739A (en) | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators | |
MX2020001756A (en) | Benzoquinolone inhibitors of vmat2. | |
MY187449A (en) | New octahydro-cyclobuta [1,2-c;3,4-c']dipyrrol-2-yl | |
MX2013002784A (en) | Fused heteroaryls and their uses. | |
EP3472176A4 (en) | Utility of (+) epicatechin and their analogs | |
IN2012MU03723A (en) | ||
UY34413A (en) | FORMULATIONS, COMPOSITIONS, METABOLITES OF CHRO MOBACTERIUM AND ITS USES | |
EP3463277A4 (en) | Formulations for substituted 3-pyrrolidines, compositions containing, and uses of, same | |
IN2013MU00848A (en) | ||
IN2014DN09450A (en) | ||
MX2015012416A (en) | Heterocyclic compounds and their uses. | |
GEP201706626B (en) | Synthesis of (s)-nifuratel | |
IN2014DN10691A (en) | ||
EP3373942A4 (en) | Compositions and methods for increasing hepatocyte functional lifetimein vitro | |
EP3426238A4 (en) | Curcumin-based compositions&methods of use thereof | |
EP3085701A4 (en) | N, n' substituted piperidinamine compounds, and preparation method and usage thereof | |
EP3650451A4 (en) | Compounds and their uses as fluorescent probes | |
EP3664826A4 (en) | Boysenberry, apple, and blackcurrant compositions and methods of preparation and use therefor |